Full text is available at the source.
Abstract
Dysbiosis in gut microbiota is associated with dyslipidemia, a significant risk factor for cardiovascular diseases.
- Dysbiosis refers to an imbalance in gut microbiota that may influence the development of metabolic diseases.
- Dyslipidemia is a disorder that involves abnormal lipid levels and is influenced by genetic and environmental factors.
- The gut microbiota plays a crucial role in maintaining lipid balance and interacts with the immune, metabolic, and endocrine systems.
- Microbiota-derived metabolites, including bile acids, lipopolysaccharides, and short-chain fatty acids, may modulate lipid levels and affect hyperlipidemia.
- Therapeutic interventions aimed at correcting lipid imbalances could involve probiotics, prebiotics, synbiotics, and dietary modifications.
Simplified